Skip to content
Search

Latest Stories

NICE issues guideline on shared decision making

The NICE has issued new guideline which sets out ways for healthcare professionals, including community pharmacists, to work with people using services to make decisions about their treatment and care and to ensure that it is the best practice at an organisational level.

The National Institute for Health and Care Excellence (NICE) said “shared decision making should be part of everyday practice across all healthcare settings. The guideline sets out ways for healthcare professionals to work with people using services to make decisions about their treatment and care, and to ensure this is best practice at an organisational level.”


Shared decision making is a collaborative process that involves a person and their healthcare professional working together to reach a joint decision about care.

The new guideline offers advice on how to engage with people accessing care in the shared decision-making process through honest conversation and by providing information resources before, during, and after appointments. The use of posters and patient decision aid leaflets are recommended to help the process.

As part of a package of resources to accompany the shared decision making guideline, NICE has collaborated with Keele University to develop a learning package, aimed at healthcare professionals, to help with implementing these recommendations.

Prof Katie Maddock, head of Keele University's School of Pharmacy and Bioengineering, said: "The School of Pharmacy and Bioengineering is delighted to have been able to share our expertise in both shared decision making and the delivery of online education with the specialists at NICE to develop this new learning package.

“This new resource will enable practitioners from all healthcare professions to develop and put into practise the skills required for shared decision making which is a fundamental component of person-centred care. We are very much looking forward to the release of the education package alongside the new NICE guideline and also to evaluating its use within healthcare.

“We’ve been delighted to collaborate with our partners to develop this guideline, the patient decision aid framework, and the learning package to fully support bringing these recommendations to the healthcare system.”

Prof Gillian Leng, NICE chief executive, said: “We’re delighted to see this shared decision making guideline published and we hope it will help people using healthcare services feel more confident in discussing care and treatment options with their healthcare teams.

“These recommendations should help healthcare professionals to embed good practice in all their interactions with the people they are caring for and at an organisational level.

“We view these recommendations as underpinning the implementation of all NICE’s work, and it’s important that these recommendations are put into practice at all levels across the system to support patient care.”

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less